BC Platforms
Zurich, CH · Founded 2015 · Switzerland corporation · 2 known investors
BC Platforms provides AI-enabled, federated data technology and predictive analytics that give healthcare and life sciences organizations access to real-world patient and genomic data for drug development and precision medicine. It serves pharmaceutical companies and healthcare organizations across the US, Europe, Asia-Pacific, and the Middle East.
Founders & leadership
ND
Nino da SilvaExecutive
TS
Tero SilvolaExecutive
Board
HV
Hannu VaajoensuuBoard director
JH
Jari HeikkinenBoard director
EP
Erich PlatzerBoard director
MB
Mark BidwellBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 1 round · 2016
▶$1.7MraisedDec 2016 · 3 investors · Other TechnologyRule 506(b)
▶$1.7MraisedDec 2016 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Hannu VaajoensuuDirector
- Jari HeikkinenDirector
- Nino da SilvaExecutive Officer
- Tero SilvolaExecutive Officer, Director
- Erich PlatzerDirector
- Mark BidwellDirector
- Offering amount
- $3M
- Amount sold
- $1.7M
- First sale
- Sep 2016
- Incorporated
- Corporation, Switzerland, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLabcorp10 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Iconplc7 shared keywordsICON is a clinical research organization that provides drug and medical device development services, including full-service outsourcing, early clinical and bioanalytical solutions, specialty laboratories, cardiac safety monitoring, market access consulting, and AI-enabled clinical trial platforms. It serves pharmaceutical companies, biotech firms, and other trial sponsors across the clinical trial lifecycle.
Medidata7 shared keywordsMedidata provides a cloud platform for clinical research that connects study, patient, and data workflows, including tools like Clinical Data Studio for data management, risk management, and medical review. It serves pharmaceutical and life sciences organizations running clinical trials, applying AI across the trial lifecycle.
Companies competing with BC Platforms for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does BC Platforms do?
- BC Platforms provides AI-enabled, federated data technology and predictive analytics that give healthcare and life sciences organizations access to real-world patient and genomic data for drug development and precision medicine. It serves pharmaceutical companies and healthcare organizations across the US, Europe, Asia-Pacific, and the Middle East.
- Who are BC Platforms's investors?
- BC Platforms's investors include Jolt Capital, StartAngels Network.
- How much funding has BC Platforms raised?
- BC Platforms has disclosed $1.7M raised across 1 round.
- Where is BC Platforms headquartered?
- BC Platforms is headquartered in Zurich, CH.